The Effectiveness of Medical Therapies for Joint, Skin and Eye Extraintestinal Manifestations in IBD—An Umbrella Review
Alimentary Pharmacology & Therapeutics · 2025-06 · 61 (12) · 1854-1871
DOI: 10.1111/apt.70181 ↗At a glance
Systematische Übersicht in Alimentary Pharmacology & Therapeutics, published online on 2025-05-06. Written by Olga M Nardone and 9 co-authors. Institution: Gastroenterology, Department of Public Health, University Federico II of Naples, Naples, Italy. Major MEDLINE topics: Inflammatory Bowel Diseases, Eye Diseases, Skin Diseases, Joint Diseases. Cited 14 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background
Extraintestinal manifestations (EIMs) occur commonly in patients with inflammatory bowel disease (IBD), affecting joints, skin, eyes and other organs, and contributing to morbidity and long‐term disability.
Aims
To synthesise evidence from systematic reviews (SRs) on the effectiveness and safety of medical treatments for IBD EIMs in IBD of joints, skin and eyes.
Methods
For this umbrella review, we searched three databases for relevant SRs published until May 30, 2024. Two independent reviewers performed screening, data extraction and quality appraisal (AMSTAR‐2).
Results
Ten, 12 and six SRs, respectively, provided data on medical therapies for articular, dermatological and ocular manifestations. Anti‐TNF therapy showed high response rates for axial (59.1%–61.8%) and peripheral arthritis (73.4%–81.2%). The lowest improvement was in patients treated with vedolizumab for joint manifestations. Ustekinumab was effective for arthralgia and psoriatic arthritis, but not for axial spondylarthritis. High heterogeneity of response was reported for anti‐TNF, vedolizumab, ustekinumab and tofacitinib (21%–100%) depending on the dermatological manifestation. No SRs evaluated IL‐23 p40 antagonists or other oral small molecules. The incidence of new ocular EIMs was 1% for vedolizumab and ustekinumab. Anti‐TNF agents were effective for most ocular EIM cases. Ustekinumab improved ocular symptoms in 55%–59%. Safety data were limited, with evidence certainty ranging from moderate to low.
Conclusions
Evidence for medical therapies for joint, skin and eye EIMs in IBD is heterogeneous and of low quality. Further research is needed, including a multidisciplinary approach and novel and practical methods for endpoint evaluation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Gastroenterology, Department of Public Health, University Federico II of Naples, Naples, Italy.
- Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK.
- Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, Canada.
- Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
- Department of Gastroenterology, Unidade Local de Saúde Gaia Espinho, Vila Nova de Gaia, Portugal.
ORCID profiles: Olga M Nardone, Nurulamin M Noor, Yuhong Yuan, Vipul Jairath, Maria Manuela Estevinho, Virginia Solitano
Cite
APA
Nardone, O. M., Noor, N. M., Prabhu, A., Lim, A., Krishnakumar, A., Alajmi, A., Yuan, Y., Jairath, V., Estevinho, M. M., & Solitano, V. (2025). The Effectiveness of Medical Therapies for Joint, Skin and Eye Extraintestinal Manifestations in IBD—An Umbrella Review. Alimentary Pharmacology & Therapeutics, 61(12), 1854-1871. https://doi.org/10.1111/apt.70181
Vancouver
Nardone OM, Noor NM, Prabhu A, Lim A, Krishnakumar A, Alajmi A, et al. The Effectiveness of Medical Therapies for Joint, Skin and Eye Extraintestinal Manifestations in IBD—An Umbrella Review. Alimentary Pharmacology & Therapeutics. 2025;61(12):1854-1871. doi:10.1111/apt.70181
BibTeX
@article{Nardone2025,
author = {Nardone, Olga M and Noor, Nurulamin M and Prabhu, Aniruddh and Lim, Alessandra and Krishnakumar, Anirudh and Alajmi, Abdulaziz and Yuan, Yuhong and Jairath, Vipul and Estevinho, Maria Manuela and Solitano, Virginia},
title = {The Effectiveness of Medical Therapies for Joint, Skin and Eye Extraintestinal Manifestations in IBD—An Umbrella Review},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
volume = {61},
number = {12},
pages = {1854--1871},
doi = {10.1111/apt.70181}
}
EUVIMED